Program overview
Context
Indication: Intrahepatic Cholangiocarcinoma
Mechanism: Unknown
Modality: Unknown
Sponsor: Fudan University
Timeline Staleness Signal
Camrelizumab
Camrelizumab is flagged as timeline staleness signal because public records show timeline staleness, public results not found after completion. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 1/5
Timeline: 3/5
Recruitment burden: 1/5
Results availability: 3/5
Program risk: 4/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT04299581 | https://clinicaltrials.gov/study/NCT04720131
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT04299581 | Low Signal (RECRUITING) | stale_update_signal | primary_completion_date_past_signal | long_recruitment_duration_signal | Low Signal | None |
| NCT04720131 | Low Signal (COMPLETED) | stale_update_signal | Completed No Results Found Signal | rare_population_signal |